iSpecimen Inc. (ISPC)
NASDAQ
Key stats Fiscal year 2025
Income statement
- Revenue
- 1,928,998 -79.2%
- Net income
- -10,487,532
- Operating income
- -8,977,919
- Earnings per share
- -2.28
Growth and profitability
- Operating margin
- -465.42
- Net margin
- -543.68
- Return on equity
- -339.60
- Return on assets
- -110.03
- Free cash flow margin
- -219.86
Balance sheet
- Total assets
- 9,531,410
- Total liabilities
- 6,443,179
- Shareholders' equity
- 3,088,231
- Cash and equivalents
- 6,880,835
- Current ratio
- 1.12
Cash flow and ratios
- Operating cash flow
- -4,240,608
- Free cash flow
- -4,241,062
Shareholder returns
- Shares outstanding
- 2,518,590
- Book value per share
- 1.23
Company information
- Headquarters
- Woburn, MA
- Exchange
- NASDAQ
- Fiscal year end
- 12-31
- Industry (SEC)
- Services-Commercial Physical & Biological Research
Fiscal year end: · Source: SEC EDGAR
iSpecimen Inc. trades on NASDAQ under the ticker symbol ISPC. This page brings together its price chart, company profile, key financial figures and technical indicators.